Mylicon children oral drops 6.66% - contrasts aerophagia and meteorism 30 ml

Product Description

Oral Drops

Composition:

1 ml of solution contains Active ingredient: simethicone (activated dimethylpolysiloxane) 66.6 mg For the full list of excipients, see 6.1

Excipients

Citric acid monohydrate; Sodium citrate; Methylhydroxypropylcellulose; Carboxypolymethylene; Saccharin; Sodium benzoate; Sorbic acid; Sodium bicarbonate; Raspberry essence; Concentrated vanilla essence; Purified water

Therapeutic indications

Symptomatic treatment of gastrointestinal meteorism and aerophagia in infants and children.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Generally contraindicated in pregnancy (see section 4.6).

Dosage

Infants and children: 20 drops (= 0.6 ml), 2-4 times a day, preferably after meals or otherwise as prescribed by your doctor. Shake well before use.

Warnings and precautions

Do not exceed the recommended dose. After a short period of treatment (7 days) without appreciable results, consult your doctor.

Interactions

No incompatibilities with other drugs are known, nor have they been reported.

Side effects

No side effects due to Mylicon have been highlighted.

Pregnancy and breastfeeding

Pregnancy. There are no adequate data on the use of Mylicon in pregnant women, therefore it should not be used during pregnancy unless really necessary and after a risk/benefit assessment by the doctor. Breastfeeding. It is not known whether simethicone is excreted in breast milk. The excretion of simethicone in breast milk has not been studied in animals. The decision whether to continue/discontinue breastfeeding or to continue/discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the child and the benefit of simethicone therapy for the woman.